23 March, 2017 Update on Dutch startup environment and impact of international tax developments on your business by Loyens & Loeff
This Seminar has unfortunately been postponed by Loyens & Loeff to a later date this autumn. We apologize for the inconvenience.
Founding or funding a startup in the Netherlands? The Startup Team of Loyens & Loeff will tell you about the practical do’s and don’ts
Are Dutch holding, financing and IP companies still viable for Nordic groups? Loyens & Loeff will update you on the impact of BEPS and EU tax developments on Nordic multinationals with business in the Netherlands
Current developments in the Dutch startup environment
If you are starting up a business in the Netherlands, or if you are investing in a startup, what are the legal and tax challenges and opportunities you should be aware of?
The Loyens & Loeff startup team will give insight in the current developments in the startup environment in the Netherlands, both from the perspective of startups and investors, with a particular focus on the Nordic countries. StartupAmsterdam – the public / private initiative working for and with the startup ecosystem of Amsterdam – will give an introduction
Impact of international tax developments on Nordic multinationals
In a rapidly changing international tax environment, it is key to understand the impact of recent developments on Nordic multinationals with businesses and corporate structures in the Netherlands. We will have a look at how various new measures against Base Erosion and Profit Shifting (BEPS) are affecting these companies. For example, are Dutch holding, group financing and intellectual property companies still viable? And what is the impact of country-by-country reporting and the exchange of tax rulings?
Loyens & Loeff
Fred. Roeskestraat 100
1076 ED Amsterdam
16.00 – 16.15: Opening / about Loyens & Loeff
16.15 – 17.10: Impact of international tax developments on Nordic multinationals
17.10 – 18.00: Current developments in the Dutch startup environment
18.00: Drinks
Non Members (Guest)
About Loyens & Loeff
Our strengths
• Legal and tax advice second to none
• Full-service practice
• Independent with an international scope
• Innovative and pragmatic
• Focused and engaged
Full-service practice
As a leading firm, Loyens & Loeff is the natural choice for a legal and tax partner if you do business in or from the Netherlands, Belgium, Luxembourg and Switzerland, our home markets. You can count on personal advice from any of our 900 advisers based in one of our offices in the Benelux and Switzerland or in key financial centres around the world. Thanks to our full-service practice, specific sector experience and thorough understanding of the market, our advisers comprehend exactly what you need.
Independent and international
As a fully independent law firm, Loyens & Loeff is excellently positioned to coordinate international tax and legal matters. We have our own network of offices in major financial centres, staffed with specialists in Dutch, Belgian, Luxembourg and Swiss law. Through these offices, our clients have access to Loyens & Loeff’s full-service legal expertise in their own time zone. Our office network is complemented by our several country desks all of which are experienced in structuring investments all over the world. It’s a winning combination that enables us to assist international clients in a very effective way. Moreover, we are on excellent terms with other leading independent law firms and tax consultants. That way, we can guarantee you top-level advice in every part of the world.
Innovative and pragmatic
Each problem requires a customised solution. Our pragmatic approach and drive to devise innovative solutions allow us to effectively address the demands of our clients’ domestic and international businesses. Thanks to the broad range of our legal experience, know-how and the size of our practices, we can offer you top-level advice, locally and internationally. We are committed to meeting your needs at the highest quality level in the most efficient way.
Focused and engaged
Entrepreneurship, client focus, quality awareness, and social engagement all characterise our firm’s culture. We offer a challenging work environment and equal opportunities for all our employees. We are mindful of the environment and help charities with the support and knowledge of our employees.
Recommended events
Business Women Program 2020 – Session 4: More information tba.
About the Swedish Chamber of Commerce Women Business Leadership Program 2020
As an ambitious hardworking goal-oriented businesswoman we invite you to participate in Swedish Chamber of Commerce’s Business Women Leadership Program 2020 to elevate your greatness. We know that coming together in a group with like minded people increases the inspiration and motivation to take the action steps needed.
The sessions will provide the tools and guidance for you to move forward and develop an effortless kind of leadership that gives you the inspiration and energy you want in your everyday life.
This year’s focus is HEALTH!
Example of Topics that will be discussed:
- Mental health and the correlation with finding your balance
- Self-confidence
- Exercise, what kind, why
- Morning rituals/routines
- Refill with fresh Energy
This is the final date for the Swedish Chamber Woman Leadership Program this year.
Time: 10.00 – 11.00 CET
Webinar
The Swedish Chamber of Commerce have the pleasure of inviting you to an exclusive Member Business Webinar on October 28, 2020 about AstraZeneca’s reponse to COVID.
The COVID-19 pandemic is placing immediate challenges on our healthcare systems and will also have a longer lasting impact on the way we live and think about our health – and that of others – in the years to come. As ever, AstraZeneca prioritizes the needs of patients to help ensure their safety and continued access to care. In addition, AstraZeneca plays their part in helping to relieve the pressure on healthcare systems during this critical period as well as our future recovery. Ilse van Hensbeek, medical director of AstraZeneca Netherlands, will elaborate on AstraZeneca’s response to COVID, and the efforts that entails. In addition to partnering with the University of Oxford to deliver a working vaccine, AstraZeneca researches monoclonal antibody combinations as well as the use registered treatment to combat the severe complications of the virus.
PROGRAM
10.00 Welcome
10.05 Introduction AstraZeneca by Ad Antonisse, Director Market Access & External Affairs
10.20 Progress and challenges Corona Virus by Ilse van Hensbeek, Medical Director AstraZeneca
10.35 Q&A
10.50 Conclusion
10.55 Thank you by Swedish Chamber
11.00 End of Webinar
